CBD Life Sciences Developing Bladder Control Supplement

Comments
Loading...

LBC Bioscience Inc., a wholly owned subsidiary of CBD Life Sciences, CBDL is working towards launching a bladder control supplement.

LBC Bioscience Inc's research department is effectively doing a study on a particular supplement pertaining to control of the bladder. President & CEO Lisa Nelson stated "This product will be all natural derived from herbs in veggie capsules infused with CBD and contain 500mg! The overall goal is to create a product that can be a sleep aid along with stress relief and bladder control throughout the night."

Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In several medical applications, cannabidiol oil is used. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period.

Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products.

Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid , CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S.

Photo by Louis Reed on Unsplash

Related News

CBD Life Sciences Launches Delta-9 + Delta-8 Infused Gummies

CBD Life Sciences Debuts New Delta-9 Gummies With 400Mg of CBD

CBD Vegan Gummies Reach Amazon, CBD Life Sciences Confirms

 

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.